References
- Wei JY. Heart disease in the elderly. Cardiovasc Med 1984: 9(12): 971–82
- O'Brien JG, Kursch JE. ‘Healthy prescribing’ for the elderly: how to minimize adverse drug effects and prevent ‘dementia in a bottle.’ Postgrad Med 1987: 82(6): 147–57
- Holt PR. Gastrointestinal drugs in the elderly. Am J Gastroenterol 1986: 81(6): 403–11
- Wei JY, Gersh BJ. Heart disease in the elderly. Curr Probl Cardiol 1987: 12(1): 1–65
- Lowenthal DT. Drug therapy in the elderly: special considerations Geriatrics 1987: 42(11): 77–8, 81–2
- Schwartz JB, Abernethy DR. Cardiac drugs: adjusting their use in aging patients. Geriatrics 1987: 42(8): 31–4, 37–40
- Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986: 80(3): 435–42
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16(1): 31–41
- Maclean D, Tudhope GR. Modern diuretic treatment. BMJ 1983: 286(11): 1419–31
- Higginbotham MB, Morris KG, Williams RS, et al. Physiologic basis for the age-related decline in aerobic work capacity. Am J Cardlol 1986: 57(15): 1374–9
- Swedberg K. Use of beta blockers in Idiopathic dilated cardiomyopathy. Pract Cardiol 1986: 12(4): 88–93
- Lakatta EG, Gerstenblith G. Angell CS, et al. Diminished inotropic response of aged myocardium to catecholamines. Qrc Res 1975: 36(2): 262–9
- Klein C, Gerber JG, Gal J, et al. Beta-adrenergic receptors in the elderly are not less sensitive to timolol. Clin Pharmacol Ther 1986: 40(2): 161–4
- Gengo FM, Huntoon L, McHugh WB. Lipid-soluble and water-soluble beta-blockers: comparison of the central nervous system depressant effect. Arch Intern Med 1987: 147(1): 39–43
- Parmley WW. Meta blockers in coronary artery disease. Cardiovasc Rev Rep 1981: 2(9): 655–62
- Khan MG. Manual of cardiac drug therapy. Philadelphia: WB Saunders, 1988: 78
- Massie BM, Hirsch AT, Inouye EK, et al. Calcium channel blockers as antihypertensive agents. Am J Med 1984: 77(Suppl 4A): 135–42
- Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985: 1(8442): 1349–54
- Khan,16 p 11
- Ibid, p 13
- Lees KR, Reid JL. Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin Pharmacol Ther 1987: 41(6): 597–602
- Hockings N, Ajayi AA, Reid JL. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol 1986: 21 (4): 341–8
- Nestico PF, Morganroth J. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Cardiol Clin 1986: 4(2): 285–303
- Horowitz LN, Morganroth J. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana? J Am Coll Cardiol 1987: 9(2): 459–63
- Morganroth J. Class 1 C antiarrhythmic agents: current status. IM-Intem Med Specialist 1986: 7(7): 125–37
- Roden DM, Woosley RL. Pharmacology and clinical use of encainide. IM-Intern Med Specialist 1987: 8(4): 83–90
- Marchlinski FE, Gansher TS, Waxman HL, et al. Amiodarone pulmonary toxicity. Ann Intern Med 1982: 98(5): 839–45
- Smith TW, Braunwald E. Digitalis toxicity. In: Braunwald E, ed. Heart disease. 2d ed. Philadelphia: WB Saunders, 1984: 523
- Brown BG, Cukingnan RA, DeRouen T, et al. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation 1985: 72(1): 138–47
- Khan,16 pp 270–1
- Hirsh J. Current role of aspirin in CAD. Drug Therapy (Hosp Ed) 1987: 11(9): 22–37
- Khan,16 p 269–70
- Hirsh J, Fuster V, Salzman E. Dose antiplatelet agents: the relationship among side effects, and antithrombotic effectiveness. Chest 1986: 89(2 Suppl): 4–10S
- Khan,16 pp 143–6
- Leier CV, Unverferth DV. Dobutamine. Ann Intern Med 1983: 99(4): 490–6
- Wynne J, Brannwald E. New treatment for congestive heart failure: amrinone and 1 milrinone. J Cardiovasc Med 1984: 8(5): 393–405